EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER

被引：0
|
作者：
Khachidze, N. [1 ]
Giorgadze, E. [2 ]
Tsagareli, M. [3 ]
Dolidze, N. [2 ]
Sharikadze, N. [4 ]
Sulikashvili, T. [3 ]
Jeiranashvili, N. [3 ]
机构：
[1] Clin Curatio, Tbilisi, Georgia
[2] Natl Inst Endocrinol, Tbilisi, Georgia
[3] Natl Inst Endocrinol, Skeletal Endocrinol Unit, Tbilisi, Georgia
[4] Clin MediClub, Tbilisi, Georgia
来源：
OSTEOPOROSIS INTERNATIONAL | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P464
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [31] EFFECT OF ADJUVANT THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Tsaaareli, M.
    Giorgadze, E.
    Khachidze, N.
    Sharilcadze, N.
    Dolidze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S268 - S269
  • [32] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Christos Markopoulos
    Breast Cancer Research, 12
  • [33] Evaluation of bone mineral density in the monitoring of the effects of breast cancer treatment with aromatase inhibitors: The importance of the least significant change
    Pacifici, Stefano
    IMAGEN DIAGNOSTICA, 2014, 5 (02): : 49 - 54
  • [34] Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer
    Sakaguchi, Koichi
    Ono, Hisako
    Nakatsukasa, Katsuhiko
    Ishikawa, Takashi
    Hasegawa, Yoshie
    Takahashi, Masato
    Niikura, Naoki
    Koizumi, Kei
    Sakurai, Teruhisa
    Shigematsu, Hideo
    Takahashi, Shunji
    Taira, Shinichiro
    Suzuki, Masato
    Narui, Kazutaka
    Miura, Daishu
    Yamada, Kimito
    Yoshimura, Mana
    Shioya, Hisashi
    Konishi, Eiichi
    Isao, Yokota
    Imai, Kojiro
    Fujikawa, Kei
    Taguchi, Tetsuya
    MEDICINE, 2019, 98 (32)
  • [35] Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study
    Nakatsukasa, Katsuhiko
    Koyama, Hiroshi
    Ouchi, Yoshimi
    Sakaguchi, Kouichi
    Fujita, Yoshifumi
    Matsuda, Takayuki
    Kato, Makoto
    Konishi, Eiichi
    Taguchi, Tetsuya
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1213 - 1218
  • [36] ECHOSOUND TECHNIQUE FOR SHORT-TERM FOLLOW-UP OF THE DENOSUMAB AND AROMATASE INHIBITORS EFFECTS ON BONE MINERAL DENSITY IN BREAST CANCER PATIENTS
    Pisani, P.
    Muratore, M.
    Conversano, F.
    Casciaro, E.
    Forcignano, R.
    Ciccarese, M.
    Surico, G.
    Quarta, L.
    Quarta, E.
    Greco, A.
    De Marco, T.
    Casciaro, S.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S538 - S539
  • [37] Bone mineral density in early breast cancer patients
    Spanik, S.
    Spanikova, B.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 27 - 32
  • [38] Prior bone health history in breast cancer patients on aromatase inhibitors
    Kwan, Marilyn L.
    Lo, Joan C.
    Tang, Li
    Laurent, Cecile
    Roh, Janise M.
    Chandra, Malini
    Hahn, Theresa E.
    Hong, Chi-Chen
    Sucheston-Campbell, Lara
    Hershman, Dawn L.
    Caan, Bette J.
    Quesenberry, Charles P.
    Sternfeld, Barbara
    Ambrosone, Christine B.
    Kushi, Lawrence H.
    Yao, Song
    CANCER RESEARCH, 2014, 74 (19)
  • [39] Management of Bone Health in Breast Cancer Patients Established on Aromatase Inhibitors
    Chan, K.
    Coomaraswamy, W.
    Riddle, P.
    Barkeji, M.
    CLINICAL ONCOLOGY, 2017, 29 (06) : E98 - E98
  • [40] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Marilyn L. Kwan
    Song Yao
    Cecile A. Laurent
    Janise M. Roh
    Charles P. Quesenberry
    Lawrence H. Kushi
    Joan C. Lo
    Breast Cancer Research and Treatment, 2018, 168 : 523 - 530
12345